Pegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection

Background The impact of chronic hepatitis C (CHC) on bone mineral density (BMD) has been well studied in adults with a relative paucity of data in children, especially concerning effect of treatment with pegylated interferon (PEG-IFN) plus ribavirin (RV). In the current work, we assessed prospectiv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of pediatrics : WJP 2017-08, Vol.13 (4), p.346-352
Hauptverfasser:	Megahed, Ahmed, Salem, Nanees, Fathy, Abeer, Barakat, Tarik, Alsayed, Mona Abd El Latif, Mabood, Suzy Abd El, Zalata, Khaled R., Abdalla, Ahmed F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Absorptiometry, Photon - methods Adolescent Age Factors Bone Density - drug effects Child Child, Preschool Cohort Studies Critical Care Medicine Drug Therapy, Combination Egypt Female Follow-Up Studies Hepatitis C, Chronic - complications Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - genetics Humans Imaging Intensive Interferon-alpha - administration & dosage Male Maternal and Child Health Medicine Medicine & Public Health Original Article Pediatric Surgery Pediatrics Radiology Retrospective Studies Ribavirin - administration & dosage Sex Factors Surgery Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!